Atlas Trials

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Clinical trial NCT02298075 · COMPLETED

Trial details

NCT number
NCT02298075
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
COMPLETED
Study type
OBSERVATIONAL
Immune Thrombocytopenia
Start date
2016-04-01
Primary completion
2019-04-17
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.